Who
Gil Aharon
Director
Company insider
Files Form 4 as: Director, Neuraxis; Director, Delcath Systems.
In numbers
- Trades disclosed
- 45
- Buys
- 4
- Sells
- 0
- Bought
- $1.1M
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 16 Nov 2020
- Last trade
- 13 Aug 2026
- Last filed
- 17 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 13 Aug 2026filed 17 Aug 2026 | NRXS NeuraxisMedical Devices | SEC FORM 4 Code A | $276K43,930 at $6.28 | filing |
| 13 Aug 2026filed 17 Aug 2026 | NRXS NeuraxisMedical Devices | SEC FORM 4 Code A | $276K43,930 at $6.28 | filing |
| 29 Jul 2026filed 17 Aug 2026 | NRXS NeuraxisMedical Devices | SEC FORM 4 Code A | —2,226 | filing |
| 29 Jul 2026filed 17 Aug 2026 | NRXS NeuraxisMedical Devices | SEC FORM 4 Code A | —40,068 | filing |
| 29 Jul 2026filed 17 Aug 2026 | NRXS NeuraxisMedical Devices | SEC FORM 4 Code A | —2,226 | filing |
| 29 Jul 2026filed 17 Aug 2026 | NRXS NeuraxisMedical Devices | SEC FORM 4 Code A | —40,068 | filing |
| 13 May 2026filed 14 May 2026 | DCTH Delcath Systemsoption or derivative · Medical Devices | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 13 May 2026filed 14 May 2026 | DCTH Delcath Systemsoption or derivative · Medical Devices | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 28 Apr 2026filed 30 Apr 2026 | NRXS NeuraxisMedical Devices | SEC FORM 4 Code A | —12,304 | filing |
| 28 Apr 2026filed 30 Apr 2026 | NRXS NeuraxisMedical Devices | SEC FORM 4 Code A | —221,917 | filing |
| 28 Apr 2026filed 30 Apr 2026 | NRXS NeuraxisMedical Devices | SEC FORM 4 Code A | —12,304 | filing |
| 28 Apr 2026filed 30 Apr 2026 | NRXS NeuraxisMedical Devices | SEC FORM 4 Code A | —221,917 | filing |
| 22 Jan 2026filed 30 Jan 2026 | NRXS NeuraxisMedical Devices | SEC FORM 4 Code A | $100K21,598 at $4.63 | filing |
| 22 Jan 2026filed 30 Jan 2026 | NRXS NeuraxisMedical Devices | SEC FORM 4 Code A | $100K21,598 at $4.63 | filing |
| 23 Dec 2025filed 29 Dec 2025 | NRXS NeuraxisMedical Devices | SEC FORM 4 Bought | $1.0M286,138 at $3.52 | filing |
| 15 May 2025filed 19 May 2025 | DCTH Delcath Systemsoption or derivative · Medical Devices | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 5 May 2025filed 9 May 2025 | DCTH Delcath SystemsMedical Devices | SEC FORM 4 Code X | $4.0M400,000 at $10.00 | filing |
| 24 Dec 2024filed 26 Dec 2024 | DCTH Delcath Systemsoption or derivative · Medical Devices | SEC FORM 4 Code M | $6.0M603,954 at $9.99 | filing |
| 24 Dec 2024filed 26 Dec 2024 | DCTH Delcath SystemsMedical Devices | SEC FORM 4 Code C | $2.5M250,000 at $10.00 | filing |
| 30 Oct 2024filed 1 Nov 2024 | DCTH Delcath Systemsoption or derivative · Medical Devices | SEC FORM 4 Code M | $500K500 at $1,000.00 | filing |
News
Head to Head Contrast: Green Thumb Industries (OTCMKTS:GTBIF) vs. NeurAxis (NASDAQ:NRXS)NRXS · dailypolitical.com · 18 Oct 2026Reviewing NeurAxis (NASDAQ:NRXS) & NovoCure (NASDAQ:NVCR)NRXS · tickerreport.com · 15 Oct 2026Critical Analysis: Solventum (NYSE:SOLV) vs. NeurAxis (NASDAQ:NRXS)NRXS · themarketsdaily.com · 10 Oct 2026
0 headlines in the last 90 days name Gil Aharon; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.